Laseroptek Co., Ltd.

Laseroptek manufactures and distributes medical laser systems for aesthetic and dermatological treatments. The company specializes in Q-switched Nd:YAG and picosecond pulse laser technologies for indications including benign pigmented lesions, tattoo removal, skin rejuvenation, scar revision, acne scars, fine lines and wrinkles, vitiligo, psoriasis, and atopic dermatitis. Primary product lines include the PicoLO Premium (picosecond Nd:YAG 1064nm and 532nm wavelengths with advanced handpiece technologies), Helios III (dual-wavelength Q-switched Nd:YAG with five operational modes), and Helios 785 (combining picosecond 785nm with nanosecond 1064nm and 532nm capabilities). Laseroptek emphasizes in-house R&D, stable laser generation, and customizable treatment parameters for physician flexibility. The company serves aesthetic practices, dermatology clinics, and medical spas throughout the US. Devices are designed for safe, precise, and clinically efficacious procedures. Company has been operational for at least 15 years based on physician testimonials. No specific FDA clearance or regulatory certifications are stated on the website.